Related Experiment Video
Updated: Mar 10, 2026

06:45
Microdissection and Whole Mount Scanning Electron Microscopy Visualization of Mouse Choroid Plexus
Published on: December 16, 2022
5.7K
Barrier function in the peripheral and central nervous system-a review.
1Department of Anesthesiology, University Hospitals Wuerzburg, Oberduerrbacher Str. 6, 97080, Wuerzburg, Germany. reinhold_a@ukw.de.
Pflugers Archiv : European Journal of Physiology
|December 14, 2016
Summary
Neural barriers like the blood-brain barrier protect the central nervous system (CNS) and peripheral nervous system (PNS). Disruption worsens neurological diseases, while intact barriers hinder drug delivery, necessitating new therapies.
Area of Science:
- Neuroscience
- Cell Biology
- Physiology
Background:
- The central nervous system (CNS) and peripheral nervous system (PNS) are vital structures requiring protection from harmful stimuli.
- Specialized barriers, including the blood-brain barrier (BBB), blood-nerve barrier (BNB), and blood-spinal cord barrier (BSCB), safeguard these systems.
Purpose of the Study:
- To detail the anatomy and function of neural barriers (BNB, BBB, BSCB).
- To identify key tight junction (TJ) proteins crucial for nervous system barrier integrity.
- To explore the role of barrier dysfunction in neurological diseases and its impact on drug delivery.
Main Methods:
- Review of anatomical and functional aspects of neural barriers.
- Identification and description of relevant tight junction proteins (e.g., claudins, occludin, ZO-1, tricellulin).
- Analysis of the impact of diseases on barrier permeability and function.
Main Results:
- Identified claudin-1, -3, -5, -11, -12, -19, occludin, ZO-1, and tricellulin as key TJ proteins in neural barriers.
- Demonstrated that barrier disruption exacerbates conditions like peripheral nerve injury, inflammatory polyneuropathy, ALS, MS, spinal cord injury, and Alzheimer's disease.
- Highlighted that intact barriers impede drug delivery for neurodegenerative diseases and inflammatory pain.
Conclusions:
- Neural barrier dysfunction is a significant factor in the pathogenesis and progression of various neurological disorders.
- Understanding barrier regulation offers potential for developing novel therapeutics to modulate barrier function for treating neurological diseases.
- Targeting neural barriers could enhance drug delivery, improving treatment efficacy for CNS and PNS conditions.
Keywords:
Alzheimer’s diseaseAmyotrophic lateral sclerosisBarrier openingBlood–brain barrierBlood–nerve barrierBlood–spinal cord barrierClaudinDrug deliveryInflammatory polyneuropathyIschemic strokeMultiple sclerosisNerve injuryOccludinSpinal cord injuryTight junctionTricellulinZO-1
